Therapeutic Group: Oncology Presentation Osicent 80: Each tablet contains Osimertinib Mesylate INN equivalent to Osimertinib 80 mg. Description Osimertinib is kinase inhibitor of the epidermal growth factor receptor (EGFR), which binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion) at approximately 9-fold lower concentrations than wild-type. In cultured cells and […]